{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T11:34:44Z","timestamp":1792409684905,"version":"4.4.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T00:00:00Z","timestamp":1600905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T00:00:00Z","timestamp":1600905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K10815"],"award-info":[{"award-number":["17K10815"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K09362"],"award-info":[{"award-number":["20K09362"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s10143-020-01395-z","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T03:45:12Z","timestamp":1600919112000},"page":"2191-2200","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pre-operative higher hematocrit and lower total protein levels are independent risk factors for cerebral hyperperfusion syndrome after superficial temporal artery\u2013middle cerebral artery anastomosis with pial synangiosis in adult moyamoya disease patients\u2014case-control study"],"prefix":"10.1007","volume":"44","author":[{"given":"Masahito","family":"Katsuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0991-0516","authenticated-orcid":false,"given":"Miki","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Tashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutake","family":"Tomata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taketo","family":"Nishizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teiji","family":"Tominaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,24]]},"reference":[{"key":"1395_CR1","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1161\/STROKEAHA.114.005624","volume":"45","author":"WS Cho","year":"2014","unstructured":"Cho WS, Kim JE, Kim CH, Ban SP, Kang HS, Son YJ, Bang JS, Sohn CH, Paeng JC, Oh CW (2014) Long-term outcomes after combined revascularization surgery in adult moyamoya disease. Stroke 45:3025\u20133031. https:\/\/doi.org\/10.1161\/STROKEAHA.114.005624","journal-title":"Stroke"},{"key":"1395_CR2","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2176\/nmc.52.327","volume":"52","author":"M Fujimura","year":"2012","unstructured":"Fujimura M, Tominaga T (2012) Lessons learned from moyamoya disease: outcome of direct\/indirect revascularization surgery for 150 affected hemispheres. Neurol Med Chir (Tokyo) 52:327\u2013332. https:\/\/doi.org\/10.2176\/nmc.52.327","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"1395_CR3","doi-asserted-by":"publisher","first-page":"793","DOI":"10.3171\/2016.11.JNS161688","volume":"128","author":"JP Jeon","year":"2018","unstructured":"Jeon JP, Kim JE, Cho WS, Bang JS, Son YJ, Oh CW (2018) Meta-analysis of the surgical outcomes of symptomatic moyamoya disease in adults. J Neurosurg 128:793\u2013799. https:\/\/doi.org\/10.3171\/2016.11.JNS161688","journal-title":"J Neurosurg"},{"key":"1395_CR4","doi-asserted-by":"publisher","unstructured":"Tominaga T, Suzuki N, Miyamoto S, Koizumi A, Kuroda S, Takahashi JC, Fujimura M, Houkin K (2018) [Recommendations for the management of moyamoya disease: a statement from research committee on spontaneous occlusion of the circle of Willis (moyamoya disease)] [2nd Edition]. Surg Cereb Stroke 46:1-24 (jpn). doi: https:\/\/doi.org\/10.2335\/scs.46.1","DOI":"10.2335\/scs.46.1"},{"key":"1395_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1161\/STROKEAHA.115.010819","volume":"47","author":"JC Takahashi","year":"2016","unstructured":"Takahashi JC, Funaki T, Houkin K, Inoue T, Ogasawara K, Nakagawara J, Kuroda S, Yamada K, Miyamoto S (2016) Significance of the hemorrhagic site for recurrent bleeding: prespecified analysis in the Japan adult moyamoya trial. Stroke 47:37\u201343. https:\/\/doi.org\/10.1161\/STROKEAHA.115.010819","journal-title":"Stroke"},{"key":"1395_CR6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.surneu.2006.07.017","volume":"67","author":"M Fujimura","year":"2007","unstructured":"Fujimura M, Kaneta T, Mugikura S, Shimizu H, Tominaga T (2007) Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease. Surg Neurol 67:273\u2013282. https:\/\/doi.org\/10.1016\/j.surneu.2006.07.017","journal-title":"Surg Neurol"},{"key":"1395_CR7","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.surneu.2008.02.031","volume":"71","author":"M Fujimura","year":"2009","unstructured":"Fujimura M, Mugikura S, Kaneta T, Shimizu H, Tominaga T (2009) Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease. Surg Neurol 71:442\u2013447. https:\/\/doi.org\/10.1016\/j.surneu.2008.02.031","journal-title":"Surg Neurol"},{"key":"1395_CR8","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1227\/NEU.0b013e318208f1da","volume":"68","author":"M Fujimura","year":"2011","unstructured":"Fujimura M, Shimizu H, Inoue T, Mugikura S, Saito A, Tominaga T (2011) Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography. Neurosurgery 68:957\u2013964; discussion 964-5. https:\/\/doi.org\/10.1227\/NEU.0b013e318208f1da","journal-title":"Neurosurgery"},{"key":"1395_CR9","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1159\/000132205","volume":"25","author":"JE Kim","year":"2008","unstructured":"Kim JE, Oh CW, Kwon OK, Park SQ, Kim SE, Kim YK (2008) Transient hyperperfusion after superficial temporal artery\/middle cerebral artery bypass surgery as a possible cause of post-operative transient neurological deterioration. Cerebrovasc Dis 25:580\u2013586. https:\/\/doi.org\/10.1159\/000132205","journal-title":"Cerebrovasc Dis"},{"key":"1395_CR10","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1159\/000336765","volume":"33","author":"M Fujimura","year":"2012","unstructured":"Fujimura M, Inoue T, Shimizu H, Saito A, Mugikura S, Tominaga T (2012) Efficacy of prophylactic blood pressure lowering according to a standardized post-operative management protocol to prevent symptomatic cerebral hyperperfusion after direct revascularization surgery for moyamoya disease. Cerebrovasc Dis 33:436\u2013445. https:\/\/doi.org\/10.1159\/000336765","journal-title":"Cerebrovasc Dis"},{"key":"1395_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1227\/NEU.0000000000000238","volume":"74","author":"M Fujimura","year":"2014","unstructured":"Fujimura M, Niizuma K, Inoue T, Sato K, Endo H, Shimizu H, Tominaga T (2014) Minocycline prevents focal neurological deterioration due to cerebral hyperperfusion after extracranial-intracranial bypass for moyamoya disease. Neurosurgery 74:163\u2013170. https:\/\/doi.org\/10.1227\/NEU.0000000000000238","journal-title":"Neurosurgery"},{"key":"1395_CR12","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1161\/STROKEAHA.116.013304","volume":"47","author":"H Uchino","year":"2016","unstructured":"Uchino H, Nakayama N, Kazumata K, Kuroda S, Houkin K (2016) Edaravone reduces hyperperfusion-related neurological deficits in adult moyamoya disease: historical control study. Stroke 47:1930\u20131932. https:\/\/doi.org\/10.1161\/STROKEAHA.116.013304","journal-title":"Stroke"},{"key":"1395_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1159\/000504835","volume":"48","author":"M Kameyama","year":"2019","unstructured":"Kameyama M, Fujimura M, Tashiro R, Sato K, Endo H, Niizuma K, Mugikura S, Tominaga T (2019) Significance of quantitative cerebral blood flow measurement in the acute stage after revascularization surgery for adult moyamoya disease: implication for the pathological threshold of local cerebral hyperperfusion. Cerebrovasc Dis 48:217\u2013225. https:\/\/doi.org\/10.1159\/000504835","journal-title":"Cerebrovasc Dis"},{"key":"1395_CR14","doi-asserted-by":"publisher","first-page":"e388","DOI":"10.1016\/j.wneu.2018.02.190","volume":"114","author":"K Kazumata","year":"2018","unstructured":"Kazumata K, Uchino H, Tokairin K, Ito M, Shiga T, Osanai T, Kawabori M (2018) Cerebral hyperperfusion syndrome after revascularization surgery in moyamoya disease: region-symptom mapping and estimating a critical threshold. World Neurosurg 114:e388\u2013e395. https:\/\/doi.org\/10.1016\/j.wneu.2018.02.190","journal-title":"World Neurosurg"},{"key":"1395_CR15","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1159\/000500802","volume":"47","author":"R Tashiro","year":"2019","unstructured":"Tashiro R, Fujimura M, Kameyama M, Mugikura S, Endo H, Takeuchi Y, Tomata Y, Niizuma K, Tominaga T (2019) Incidence and risk factors of the watershed shift phenomenon after superficial temporal artery-middle cerebral artery anastomosis for adult moyamoya disease. Cerebrovasc Dis 47:178\u2013187. https:\/\/doi.org\/10.1159\/000500802","journal-title":"Cerebrovasc Dis"},{"key":"1395_CR16","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1161\/STROKEAHA.112.654723","volume":"43","author":"H Uchino","year":"2012","unstructured":"Uchino H, Kuroda S, Hirata K, Shiga T, Houkin K, Tamaki N (2012) Predictors and clinical features of post-operative hyperperfusion after surgical revascularization for moyamoya disease: a serial single photon emission CT\/positron emission tomography study. Stroke 43:2610\u20132616. https:\/\/doi.org\/10.1161\/STROKEAHA.112.654723","journal-title":"Stroke"},{"key":"1395_CR17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s003810050044","volume":"13","author":"K Sato","year":"1997","unstructured":"Sato K, Shirane R, Yoshimoto T (1997) Perioperative factors related to the development of ischemic complications in patients with moyamoya disease. Childs Nerv Syst 13:68\u201372. https:\/\/doi.org\/10.1007\/s003810050044","journal-title":"Childs Nerv Syst"},{"key":"1395_CR18","doi-asserted-by":"publisher","first-page":"e158","DOI":"10.1016\/j.wneu.2019.12.072","volume":"136","author":"JW Choi","year":"2020","unstructured":"Choi JW, Chong S, Phi JH, Lee JY, Kim HS, Chae JH, Lee J, Kim SK (2020) Post-operative symptomatic cerebral infarction in pediatric moyamoya disease: risk factors and clinical outcome. World Neurosurg 136:e158\u2013e164. https:\/\/doi.org\/10.1016\/j.wneu.2019.12.072","journal-title":"World Neurosurg"},{"key":"1395_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1179\/1743132814Y.0000000432","volume":"37","author":"M Fujimura","year":"2015","unstructured":"Fujimura M, Niizuma K, Endo H, Sato K, Inoue T, Shimizu H, Tominaga T (2015) Quantitative analysis of early post-operative cerebral blood flow contributes to the prediction and diagnosis of cerebral hyperperfusion syndrome after revascularization surgery for moyamoya disease. Neurol Res 37:131\u2013138. https:\/\/doi.org\/10.1179\/1743132814Y.0000000432","journal-title":"Neurol Res"},{"key":"1395_CR20","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1093\/bja\/aes470","volume":"110","author":"JW Hwang","year":"2013","unstructured":"Hwang JW, Yang HM, Lee H, Lee HK, Jeon YT, Kim JE, Lim YJ, Park HP (2013) Predictive factors of symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in adult patients with moyamoya disease. Br J Anaesth 110:773\u2013779. https:\/\/doi.org\/10.1093\/bja\/aes470","journal-title":"Br J Anaesth"},{"key":"1395_CR21","doi-asserted-by":"publisher","first-page":"e593","DOI":"10.1016\/j.wneu.2018.08.132","volume":"120","author":"K Tokairin","year":"2018","unstructured":"Tokairin K, Kazumata K, Uchino H, Ito M, Ono K, Tatezawa R, Shindo T, Kawabori M, Nakayama N, Houkin K (2018) Post-operative intracerebral hemorrhage after combined revascularization surgery in moyamoya disease: profiles and clinical associations. World Neurosurg 120:e593\u2013e600. https:\/\/doi.org\/10.1016\/j.wneu.2018.08.132","journal-title":"World Neurosurg"},{"key":"1395_CR22","doi-asserted-by":"publisher","first-page":"011905","DOI":"10.1103\/PhysRevE.84.011905","volume":"84","author":"R Tao","year":"2011","unstructured":"Tao R, Huang K (2011) Reducing blood viscosity with magnetic fields. Phys Rev E - Stat Nonlinear, Soft Matter Phys 84:011905. https:\/\/doi.org\/10.1103\/PhysRevE.84.011905","journal-title":"Phys Rev E - Stat Nonlinear, Soft Matter Phys"},{"key":"1395_CR23","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1161\/01.str.9.4.369","volume":"9","author":"H Tohgi","year":"1978","unstructured":"Tohgi H, Yamanouchi H, Murakami M, Kameyama M (1978) Importance of the hematocrit as a risk factor in cerebral infarction. Stroke 9:369\u2013374. https:\/\/doi.org\/10.1161\/01.str.9.4.369","journal-title":"Stroke"},{"key":"1395_CR24","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1001\/archneur.57.2.260","volume":"57","author":"PF Finelli","year":"2000","unstructured":"Finelli PF, Carlcy MD (2000) Cerebral venous thrombosis associated with epoetin alfa therapy. Arch Neurol 57:260\u2013262. https:\/\/doi.org\/10.1001\/archneur.57.2.260","journal-title":"Arch Neurol"},{"key":"1395_CR25","doi-asserted-by":"publisher","first-page":"827","DOI":"10.2176\/nmc.cr.2013-0261","volume":"54","author":"T Machida","year":"2014","unstructured":"Machida T, Ono J, Nomura R, Fujikawa A, Nagano O, Higuchi Y (2014) Venous reddening as a possible sign of hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis for moyamoya disease: case report. Neurol Med Chir (Tokyo) 54:827\u2013831. https:\/\/doi.org\/10.2176\/nmc.cr.2013-0261","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"1395_CR26","doi-asserted-by":"crossref","unstructured":"Fujimura M, Mugikura S, Shimizu H, Tominaga T (2006) Diagnostic value of perfusion-weighted MRI for evaluating post-operative alteration of cerebral hemodynamics following STA-MCA anastomosis in patients with moyamoya disease. No Shinkei Geka 34:801-809 (jpn)","DOI":"10.2335\/scs.34.37"},{"key":"1395_CR27","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1172\/JCI104617","volume":"41","author":"RE Wells","year":"1962","unstructured":"Wells RE, Merril EW (1962) Influence of flow properties of blood upon viscosity-hematocrit relationships. J Clin Invest 41:1591\u20131598. https:\/\/doi.org\/10.1172\/JCI104617","journal-title":"J Clin Invest"},{"key":"1395_CR28","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1186\/cc10919","volume":"82","author":"M Jungner","year":"2016","unstructured":"Jungner M, Siemund R, Venturoli D, Reinstrup P, Scsal\u00e9n W, Bentzer P (2016) Blood-brain barrier permeability following traumatic brain injury. Minerva Anestesiol 82:525\u2013533. https:\/\/doi.org\/10.1186\/cc10919","journal-title":"Minerva Anestesiol"},{"key":"1395_CR29","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.surneu.2008.10.009","volume":"72","author":"M Fujimura","year":"2009","unstructured":"Fujimura M, Watanabe M, Narisawa A, Shimizu H, Tominaga T (2009) Increased expression of serum matrix metalloproteinase-9 in patients with moyamoya disease. Surg Neurol 72:476\u2013480. https:\/\/doi.org\/10.1016\/j.surneu.2008.10.009","journal-title":"Surg Neurol"},{"key":"1395_CR30","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1136\/jnnp.2009.191817","volume":"81","author":"HS Kang","year":"2010","unstructured":"Kang HS, Kim JH, Phi JH, Kim YY, Kim JE, Wang KC, Cho BK, Kim SK (2010) Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease. J Neurol Neurosurg Psychiatry 81:673\u2013678. https:\/\/doi.org\/10.1136\/jnnp.2009.191817","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1395_CR31","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3390\/jcm8060775","volume":"8","author":"U Keller","year":"2019","unstructured":"Keller U (2019) Nutritional laboratory markers in malnutrition. J Clin Med 8:775. https:\/\/doi.org\/10.3390\/jcm8060775","journal-title":"J Clin Med"},{"key":"1395_CR32","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/1747-0080.12536","volume":"77","author":"VA Rus","year":"2020","unstructured":"Rus VA, Chitu M, Cernea S, Benedek I, Hodas R, Zavate R, Nyulas T, Hintea M, Benedek T (2020) Altered nutritional status, inflammation and systemic vulnerability in patients with acute myocardial infarction undergoing percutaneous coronary revascularisation: a prospective study in a level 3 cardiac critical care unit. Nutr Diet 77:212\u2013222. https:\/\/doi.org\/10.1111\/1747-0080.12536","journal-title":"Nutr Diet"},{"key":"1395_CR33","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00701-019-03811-w","volume":"161","author":"A Narducci","year":"2019","unstructured":"Narducci A, Yasuyuki K, Onken J, Blecharz K, Vajkoczy P (2019) In vivo demonstration of blood-brain barrier impairment in moyamoya disease. Acta Neurochir (Wien) 161:371\u2013378. https:\/\/doi.org\/10.1007\/s00701-019-03811-w","journal-title":"Acta Neurochir (Wien)"},{"key":"1395_CR34","doi-asserted-by":"crossref","unstructured":"Yu J, Zhang J, Li J, Zhang J, Chen J (2020) Cerebral hyperperfusion syndrome after revascularization surgery in patients with moyamoya disease: systematic review and meta-analysis. World Neurosurg 135:357-366.e4","DOI":"10.1016\/j.wneu.2019.11.065"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-020-01395-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-020-01395-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-020-01395-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T06:43:22Z","timestamp":1632465802000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-020-01395-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,24]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1395"],"URL":"https:\/\/doi.org\/10.1007\/s10143-020-01395-z","relation":{},"ISSN":["0344-5607","1437-2320"],"issn-type":[{"value":"0344-5607","type":"print"},{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,24]]},"assertion":[{"value":"2 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The ethical committee of Kohnan Hospital approved this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent for participation in the study was received from all subjects.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Written informed consent for publication was received from all subjects.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}